Evidence map›Paper›PMID 41796208›Full record

ArticleScientific reports2026

Predictability comparison of central corneal thickness reduction in myopic eyes with or without astigmatism undergoing FS-LASIK with two profiles of MEL 90.

Xue Jiang, Zhe Zhang, Wei Mao, Yusheng Zhou, Jian Cheng, Ya Liu, Qidi Hu

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xue JiangDepartment of Ophthalmology, Wenzhou Medical University Ningbo Eye Hospital, No. 599 Beimingcheng Road, Ningbo, 315040, China.
Zhe ZhangDepartment of Ophthalmology, Wenzhou Medical University Ningbo Eye Hospital, No. 599 Beimingcheng Road, Ningbo, 315040, China.
Wei MaoDepartment of Ophthalmology, Wenzhou Medical University Ningbo Eye Hospital, No. 599 Beimingcheng Road, Ningbo, 315040, China.
Yusheng ZhouDepartment of Ophthalmology, Wenzhou Medical University Ningbo Eye Hospital, No. 599 Beimingcheng Road, Ningbo, 315040, China.
Jian ChengNingbo Clinical Medical Research Center for Ophthalmology, Ningbo, 315040, China.
Ya LiuDepartment of Ophthalmology, The Affiliated Suzhou Hospital of Nanjing University Medical School, Suzhou, 215153, China. yy_yiye@163.com.
Qidi HuDepartment of Ophthalmology, Wenzhou Medical University Ningbo Eye Hospital, No. 599 Beimingcheng Road, Ningbo, 315040, China. nbeyehuqidi@126.com.

Funding

Ningbo Clinical Research Center for Ophthalmology 2022L003Ningbo Eye Hospital Youth Project 2023QN003the Public Welfare Research Project of Ningbo City 2024S179
6 · The paper itself

Abstract

To compare the predictability of central corneal thickness (CCT) reduction in myopic patients undergoing femtosecond laser-assisted in situ keratomileusis (FS-LASIK) using the aberration-optimized (Triple-A) and topography-guided (TG) profiles on the MEL 90 platform. This study involved 82 patients, treating one eye with the Triple-A profile and the other with the TG profile on the MEL 90, with an average spherical equivalent of - 5.76 ± 2.02 D (Triple-A) and - 5.79 ± 1.90 D (TG). Refractive assessments were done preoperatively and at 1 day, 1 week, 1 month, and 3 months postoperatively. Achieved CCT reduction (via Pentacam) = CCT

Indexed as

AstigmatismCorneaKeratomileusis, Laser In SituMyopiaAdultCorneal TopographyFemaleHumansMaleRefraction, OcularVisual AcuityYoung AdultAblation depthCentral corneal thickness reductionFS-LASIKTopography-guided profileTriple-A profile

Identifiers

PMID41796208
PMCPMC13087035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.